Time-dependent changes in hypoxia- and gliosis-related factors in experimental diabetic retinopathy.


Journal

Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986

Informations de publication

Date de publication:
04 2019
Historique:
received: 27 03 2018
accepted: 30 08 2018
revised: 21 08 2018
pubmed: 8 11 2018
medline: 14 8 2019
entrez: 8 11 2018
Statut: ppublish

Résumé

Diabetes causes various biochemical changes in the retina; long-term changes in the factors associated with hypoxia and gliosis have rarely been reported. The present study was conducted to explore the changes in these factors in a time-dependent manner in experimental diabetic retinopathy (DR). Diabetes was induced in Sprague-Dawley rats by intraperitoneal injection of streptozotocin. The expression of the following factors was examined using immunofluorescence and western blot analysis at 0.5, 1, 2, 4 and 6 months after diabetes onset: hypoxia-inducible factor-1alpha (HIF-1alpha), vascular endothelial growth factor (VEGF), erythropoietin (EPO), erythropoietin receptor (EPOR), glial fibrillary acidic protein (GFAP), vimentin, glutamate-aspartate transporter (GLAST) and glutamine synthase (GS). The expression of factors such as HIF-1alpha, VEGF, EPO, EPOR, GFAP and vimentin, was up-regulated with the progression of diabetes in the diabetic rat retinas compared to the expression in normal control retinas, whereas the expression of GS and GLAST was down-regulated. Changes in EPO and EPOR appeared 2 weeks after diabetes onset. HIF-1alpha, VEGF and GFAP started to increase at 1 month and vimentin at 4 months after diabetes onset. GS and GLAST started to decrease at 1 month after diabetes onset. The expression of these factors, which are involved in the processes of hypoxia and gliosis, varied at different stages of DR. The time-course change may be helpful in the evaluation of the progression of DR, and it may indicate the optimal intervention time points for DR.

Identifiants

pubmed: 30401898
doi: 10.1038/s41433-018-0268-z
pii: 10.1038/s41433-018-0268-z
pmc: PMC6461831
doi:

Substances chimiques

Biomarkers 0
Hypoxia-Inducible Factor 1, alpha Subunit 0
Receptors, Erythropoietin 0
Vascular Endothelial Growth Factor A 0

Types de publication

Journal Article

Langues

eng

Pagination

600-609

Références

Blood. 1999 Apr 15;93(8):2627-36
pubmed: 10194442
Invest Ophthalmol Vis Sci. 2000 Jun;41(7):1971-80
pubmed: 10845624
Nat Neurosci. 2000 Sep;3(9):873-80
pubmed: 10966617
Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3561-8
pubmed: 11006253
J Biol Chem. 2001 Mar 23;276(12):9519-25
pubmed: 11120745
Neurochem Int. 2001 Apr;38(5):385-90
pubmed: 11222918
Curr Eye Res. 2001 Oct;23(4):276-84
pubmed: 11852429
Eye (Lond). 2002 May;16(3):242-60
pubmed: 12032713
Exp Eye Res. 2002 May;74(5):615-25
pubmed: 12076083
Circ Res. 2002 Jul 12;91(1):38-45
pubmed: 12114320
Microvasc Res. 2002 Sep;64(2):326-33
pubmed: 12204656
Surv Ophthalmol. 2002 Dec;47 Suppl 2:S253-62
pubmed: 12507627
Diabetes. 2003 Feb;52(2):506-11
pubmed: 12540628
N Engl J Med. 2004 Jan 1;350(1):48-58
pubmed: 14702427
Drug Discov Today. 2004 Aug 15;9(16):704-11
pubmed: 15341784
Exp Cell Res. 2004 Oct 1;299(2):476-85
pubmed: 15350545
Mol Vis. 2004 Aug 26;10:608-17
pubmed: 15354084
Neurosci Lett. 2005 Feb 21;374(3):179-82
pubmed: 15663958
N Engl J Med. 2005 Aug 25;353(8):782-92
pubmed: 16120858
Diabetes Care. 2005 Sep;28(9):2252-4
pubmed: 16123502
Semin Cell Dev Biol. 2005 Aug-Oct;16(4-5):531-8
pubmed: 16144690
Cancer Lett. 2005 Dec 8;230(1):122-33
pubmed: 16253768
Diabetes. 2006 Sep;55(9):2401-11
pubmed: 16936187
Br J Ophthalmol. 2007 Jun;91(6):822-6
pubmed: 17229797
Br J Pharmacol. 2007 Apr;150(7):823-5
pubmed: 17351666
Curr Eye Res. 2007 Mar;32(3):233-9
pubmed: 17453943
Strahlenther Onkol. 2007 Jul;183(7):366-73
pubmed: 17609869
J Clin Invest. 2008 Feb;118(2):526-33
pubmed: 18219389
Invest Ophthalmol Vis Sci. 2008 Feb;49(2):726-31
pubmed: 18235021
Invest Ophthalmol Vis Sci. 2008 Feb;49(2):732-42
pubmed: 18235022
Diabetes Care. 2008 Jun;31(6):1189-94
pubmed: 18332162
Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1329-35
pubmed: 18952918
Exp Eye Res. 2009 Dec;89(6):967-71
pubmed: 19699197
Am J Ophthalmol. 2009 Dec;148(6):883-9
pubmed: 19837381
Front Biosci (Elite Ed). 2011 Jan 01;3:201-11
pubmed: 21196299
Cell Mol Life Sci. 2012 Jan;69(1):115-28
pubmed: 21617913
Front Biosci (Elite Ed). 2011 Jun 01;3:1541-55
pubmed: 21622158
Chin Med Sci J. 2011 Jun;26(2):69-76
pubmed: 21703113
Exp Clin Endocrinol Diabetes. 2012 Apr;120(4):199-201
pubmed: 22402950
Acta Ophthalmol. 2014 Jun;92(4):323-7
pubmed: 23718695
Clin Interv Aging. 2013;8:467-83
pubmed: 23766636
Int J Med Sci. 2013 Aug 22;10(10):1412-21
pubmed: 23983604
Trends Endocrinol Metab. 2014 Jan;25(1):23-33
pubmed: 24183659
Invest Ophthalmol Vis Sci. 2014 Mar 13;55(3):1519-30
pubmed: 24508793
PLoS One. 2014 Apr 02;9(4):e93433
pubmed: 24695675
Am J Pathol. 2014 Jun;184(6):1752-62
pubmed: 24709590
Biomed Res Int. 2014;2014:801269
pubmed: 25105142
Invest Ophthalmol Vis Sci. 2015 Apr;56(4):2773-82
pubmed: 25813994
Biomed Pharmacother. 2015 Aug;74:145-7
pubmed: 26349976
Ophthalmologica. 2016;235(1):34-41
pubmed: 26630400
Nat Rev Endocrinol. 2016 Mar;12(3):130-1
pubmed: 26794438
Br J Ophthalmol. 2016 Dec;100(12):1611-1616
pubmed: 26951773
Rom J Ophthalmol. 2016 Jan-Mar;60(1):9-13
pubmed: 27220225
J Curr Ophthalmol. 2016 Mar 30;28(1):5-11
pubmed: 27239595
JAMA Ophthalmol. 2016 Aug 1;134(8):888-96
pubmed: 27280850
Neurobiol Dis. 2016 Nov;95:82-92
pubmed: 27425889
Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H738-49
pubmed: 27473938
J Curr Glaucoma Pract. 2016 May-Aug;10(2):39-48
pubmed: 27536046
Ophthalmol Ther. 2017 Jun;6(1):33-47
pubmed: 28324452
Ophthalmology. 2017 May;124(5):619-633
pubmed: 28341474
Cochrane Database Syst Rev. 2017 Jun 22;6:CD007419
pubmed: 28639415
Diab Vasc Dis Res. 2018 May;15(3):214-222
pubmed: 29409329
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3974-8
pubmed: 8171022
Cancer Res. 1993 Aug 1;53(15):3624-31
pubmed: 8339269
Am J Physiol. 1998 Oct;275(4):L818-26
pubmed: 9755115

Auteurs

Limin Gu (L)

Department of Ophthalmology, Third Affiliated Hospital of Second Military Medical University, Shanghai, China.
Department of Ophthalmology of Shanghai Tenth People's Hospital, Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China.

Hua Xu (H)

Department of Ophthalmology of Shanghai Tenth People's Hospital, Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China.
Department of Ophthalmology, Children's Hospital of Soochow University, Suzhou, China.

Chaoyang Zhang (C)

Department of Ophthalmology of Shanghai Tenth People's Hospital, Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China.

Qian Yang (Q)

Department of Ophthalmology of Shanghai Tenth People's Hospital, Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China.

Limei Zhang (L)

Department of Ophthalmology of Shanghai Tenth People's Hospital, Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China.
Shanghai Peace Eye Hospital, Shanghai, China.

Jingfa Zhang (J)

Department of Ophthalmology of Shanghai Tenth People's Hospital, Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China. jingfazhang@tongji.edu.cn.
Department of Ophthalmology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. jingfazhang@tongji.edu.cn.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH